SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit
BEIJING--(BUSINESS WIRE)--Jun 20, 2025--
SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York.
The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board.
Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders.
Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.'
The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share.
Your Vote is Important
Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment.
We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders.
DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count!
If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at [email protected].
About SINOVAC
Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc.
The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under 'Category 1 Preventative Biological Products' and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.
SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.
SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.
Important Additional Information and Where to Find It
In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, www.sec.gov, or from SINOVAC at its website: https://www.sinovac.com/en-us/Investors/sec_filings. You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at [email protected].
Safe Harbor Statement
This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250620737835/en/
CONTACT: Investor and Media Contact
FGS Global
[email protected]
KEYWORD: CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC NEW YORK
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: The Board of Directors of Sinovac Biotech Ltd.
Copyright Business Wire 2025.
PUB: 06/20/2025 10:56 PM/DISC: 06/20/2025 10:55 PM
http://www.businesswire.com/news/home/20250620737835/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Dividend Investing: Is This High-Yield Dividend King a Buy After a Dip?
Target stock offers a dividend yield of almost 4.8%. Its stock is down nearly 65% since 2021 amid a variety of challenges. The company's dividend stability likely comes down to the strength of its free cash flow. 10 stocks we like better than Target › When it comes to income investing, many investors will turn to Dividend Kings. These stocks have increased their payouts every year for at least 50 years, drawing investors with their decades-long track record of stability. Of those stocks, Target (NYSE: TGT) has drawn attention for its relatively high yield. However, that dividend return has risen amid sales declines from a sluggish economy and public relations missteps. That leaves investors to figure out whether they should dismiss the company's challenges and pursue that yield, or stay away. Indeed, it is hard not to like Target on the surface. The footprint of nearly 2,000 stores across all 50 states bolsters the company and is a key competitive advantage. With more than 75% of the U.S. population within 10 miles of a Target location, only Walmart can surpass its ability to combine in-store and online retailing. That presence has helped support a lucrative dividend. Amid its recent payout hike, the company now pays investors $4.56 per share annually, a dividend yield of just under 4.8%. Considering the S&P 500's average yield of approximately 1.3%, Target stock could draw investors primarily for its payout. Moreover, in fiscal 2024 (ended Feb. 1), Target generated almost $4.48 billion in free cash flow, well above the $2.05 billion dividend costs, so longer-term data show Target maintains a sustainable payout. Also, the recent dividend increase has given Target a 54-year history of payout hikes, maintaining its place as a Dividend King. Admittedly, such a status does not negate its right to reduce or eliminate the payout in theory. Nonetheless, such a move would likely undermine confidence in the stock, as evidenced by the history of other companies that abandoned decades-long dividend increase streaks. With its challenges, Target's stock is down by nearly 65% from its 2021 high. But even with its rock-bottom 11 P/E ratio, a dividend cut would probably lead to further stock selling, a scenario management likely wants to avoid. However, investors may need to accept some risks and watch free cash flows. Despite its positive free cash flows in 2024, Target reported $515 million in negative free cash flow in the first quarter of fiscal 2025 (ended May 3), a time when it also had to pay $510 million in dividends. Target held $2.89 billion in cash and cash equivalents after paying dividends, so the dividend is not immediately in danger. Nonetheless, Target faces challenges that could endanger the payout if troubles persist. In Q1, revenue of $23.8 billion fell 2.8% over the previous 12 months. The 3.8% decline in year-over-year comparable sales contributed to this drop amid an uncertain economy, and higher costs related to the supply chain and digital fulfillment weighed on the company's financials. Such issues could persist as changing tariff policies could worsen supply chain pressures. Additionally, many left-leaning consumers began avoiding Target amid the company's decision to end its DEI initiatives. This is after the company alienated right-leaning consumers earlier in the decade over promoting DEI. Amid these challenges, its negative quarterly results are not a one-time event, as revenue fell 1% during fiscal 2024. The news is not all bad, as the fiscal Q1 net income of $1.04 billion rose 10% compared to the year-ago quarter. Still, that rise occurred as a result of an 11% reduction in selling, general, and administrative expenses. Since such spending cutbacks are probably not sustainable in the long run, Target will need to find a way to attract consumers if it wants to maintain long-term financial growth. Considering Target's extensive footprint, its low P/E ratio, and the ability to combine in-store and online retail, Target stock is likely a buy for its dividend yield. The stock is cheap for a reason, as an uncertain economy and the company's political activities have discouraged consumers from shopping at Target. Still, with its dividend sustainable in the long term and a 54-year streak of payout hikes, Target is likely to continue increasing its payout. Moreover, an 11 P/E ratio likely prices in the challenges Target faces, and its large footprint positions the company for a comeback. Target's value proposition is strained but probably not broken, leaving it positioned to move higher and maintain its Dividend King status. Before you buy stock in Target, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Target wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Will Healy has positions in Target. The Motley Fool has positions in and recommends Target and Walmart. The Motley Fool has a disclosure policy. Dividend Investing: Is This High-Yield Dividend King a Buy After a Dip? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Gizmodo
35 minutes ago
- Gizmodo
Before the Z Fold7 Launch, Amazon Clears Out Galaxy S25 Ultra Stock at a Ridiculous Price
In just a few weeks, Samsung is expected to announce its latest generation of foldable smartphones as it does every year. If past trends continue, we'll likely see the Galaxy Z Flip 7 and Galaxy Z Fold 7 take center stage. And even as anticipation builds for those devices, the top-selling traditional flagship remains the Galaxy S25 Ultra which is also the most high-end Android phone available today. And now, Amazon is offering a new discount on the Galaxy S25 Ultra 256GB model available for $1,049 after a great 19% discount from its $1,299 list price. The 512GB model is also available at $1,219 down from $1,419. If you're looking for the ultimate Android experience, this is an opportunity to pick up a true premium device at a price that's hard to pass up. See at Amazon The Samsung Galaxy S25 Ultra is the most impressive smartphones available today: It has a large 6.9-inch Dynamic AMOLED display with a sharp resolution of 3120 x 1440 pixels and a smooth 120Hz refresh rate which make everything look vibrant and fluid. The screen is protected by tough Corning Gorilla Glass Armor 2 and can get very bright – which is great for outdoor use. Under the hood, the Galaxy S25 Ultra is powered by the Qualcomm Snapdragon 8 Elite processor, the best chip available today which makes it extremely fast for gaming and multitasking. The device runs on the latest Android 15 operating system with Samsung's One UI which is easy to use and packed with features. The battery is a large 5000mAh (it will last over a day) and supports fast charging, wireless charging and even reverse wireless charging. The camera system features a quad rear camera setup with a main 200MP lens, a 50MP ultra-wide lens, and two telephoto lenses (one 50MP with 5x optical zoom and another 10MP with 3x optical zoom). This means that you can take detailed photos from far away or capture wide landscapes easily. The phone also has a 12MP front camera for high-quality selfies and video calls. For any user who wants the best of what Android has to offer, the Galaxy S25 Ultra is the clear choice – especially at this price point. Don't miss this opportunity. See at Amazon
Yahoo
an hour ago
- Yahoo
Global Investors Turn Their Attention to GIFPP 2025 in Bangkok, Reinforcing a New Era of Responsible Investment
BANGKOK, THAILAND / / June 21, 2025 / Amid the complex landscape of geopolitical uncertainty and transformative social dynamics, the Global Investment Forum for Peace & Prosperity (GIFPP 2025) has emerged as a significant event drawing global financial leaders and policy influencers. Held at the prestigious InterContinental Hotel Bangkok, the forum successfully gathered nearly 300 delegates from 14 countries, featuring policymakers, fund executives, development experts, startup founders, and renowned media outlets. Global Investment and Partnership for Peace and Prosperity Forum (GIFPP) A Shift Toward Responsible Investment The importance of GIFPP 2025 lies in its timely and strategic alignment with the evolving investment paradigm. As the world shifts away from traditional economic metrics, such as Return on Investment (ROI), the focus is now on Return on Humanity (ROH). This change emphasizes investments that not only generate financial returns but also foster positive societal outcomes. The forum emphasized this growing global trend, where investors increasingly look beyond short-term financial gains and place value on advancing the United Nations' 17 Sustainable Development Goals (SDGs), a framework of paramount importance for long-term, ESG-focused investors. The Forum's Impact and Strategic Vision GIFPP 2025 has positioned itself as a central platform to bridge the gap between global capital and the SDGs. Unlike many traditional forums, it encourages a sustainable investment ecosystem where startups, governments, and enterprises collaborate to create long-lasting value. According to Professor Dr. Martin Spraggon Hernandez, an Advisor to the Governments of Dubai & Abu Dhabi, "We need a new investment architecture-where technology, humanity, and social responsibility are inseparable drivers of global economic value." A Key Milestone: The Launch of 9S UNION A pivotal moment in the forum was the unveiling of 9S UNION, a groundbreaking digital global economic alliance. 9S UNION connects startups, investors, and governments through an open platform aimed at fostering economic and social development across borders. As part of the initiative, 9S UNION signed memoranda of understanding (MOUs) with 12 countries, committing to undertake at least 10 social-impact projects in sectors like education, healthcare, technology, and clean energy. These projects will span ASEAN, the Middle East, Africa, and Europe, marking the initiative as a key driver for international cooperation. The Memorandum of Understanding (MoU) signing ceremony between 9S UNION and international partners marks a concrete and meaningful commitment to collaborative action toward shared global objectives. In a statement, Dr. Francis Gaudreault, Strategic Security Advisor to the Abu Dhabi Government, emphasized, "9S UNION is a major inflection point-laying the groundwork for a global financial ecosystem based on transparency and shared responsibility." Where Finance Meets Innovation for Social Good GIFPP 2025 also featured the launch of 7S CENTER, a digital commerce hub designed to empower SMEs with the tools they need for success. Additionally, the event showcased innovative technologies utilizing AI, blockchain, and carbon tracking systems to promote financial transparency, data protection, and green finance. Speaking about the growing intersection of technology and entrepreneurship, Dinh Viet Hoa, Chairman of the Vietnam National Startup Association, remarked, "Global entrepreneurship is no longer just about tech; it's about shaping a future that prioritizes both people and the planet." Vietnam's Role in Responsible Investment As a co-organizer of the event, the Vietnam National Startup Innovation Forum (VNSIF) played an instrumental role in shaping the content of GIFPP 2025. VNSIF's efforts underscored Vietnam's commitment to fostering an investment environment centered on social responsibility and sustainable development. Through collaborative platforms like 9S UNION and 7S CENTER, Vietnam is actively shaping a global investment landscape that prioritizes long-term impact over immediate financial returns. Beyond Dialogue: Action-Oriented Collaboration In a departure from the typical format of traditional investment forums, GIFPP 2025 served as a springboard for actionable outcomes. Through B2B meetings, technology showcases, and cultural exchange galas, the event fostered genuine collaboration that is expected to drive long-term action. GIFPP 2025 is not just about deal-making; it's a space for recalibrating investment strategies to align with the growing demands for responsibility, stability, and positive societal impact. This commitment to building a future where profitability walks hand in hand with peace positions GIFPP as a key milestone for the next phase of global investment. As the world enters a new phase of uncertainty, GIFPP 2025 offers a strategic waypoint-a reminder that investment can be much more than the flow of capital; it is a force for global responsibility, stability, and hope. Certainly! Here's an additional paragraph that ties in the broader themes of the forum: About GIFPP 2025 GIFPP 2025 is a global forum focused on using investment to drive positive change. By bringing together policymakers, entrepreneurs, and investors, it promotes collective action to address key challenges. The forum emphasizes purpose-driven investment, aiming for economic prosperity, environmental sustainability, and equitable opportunities for all. ____________ Media Contact Organization: 9S UnionContact Person: Ivanka DoWebsite: SOURCE: 9S Union View the original press release on ACCESS Newswire Sign in to access your portfolio
